Dimitri P. Mikhailidis graduated from the University of London (BSc, MSc, MB, BS and MD) and is an Honorary Professor in the Division of Surgery and Interventional Science at the University College London Medical School, University College London (UCL). He is the former Academic Head in the Department of Clinical Biochemistry at the Royal Free Hospital Campus (UCL), and an Adjunct Professor of Medicine since 2019 at theMohammed Bin Rashid University (MBRU), Dubai. He is also a Visiting Professor at the University of Belgrade, Serbia and at two other universities in Saudi Arabia. His research interests are dyslipidemias and thrombosis. He is a Fellow of the Royal College of Pathologists (FRCPath) and Royal College of Physicians (FRCP). He has 38,395 citations on the Clarivate Core Collection (H-index 89).
Dr. Michael Dashwood PhD has over 40 years’ of research experience. Previously his study area was the central nervous system involved in pain and cardiovascular control and currently in vascular biology. Initially, he was employed at the Medical Research Council’s National Institute for Medical Research in London involved in studies of the central sites of opioid induced nociception and cardiovascular actions. After obtaining an MSc in pharmacology and a PhD in Physiology at the Royal Free Hospital, London, Dr. Dashwood’s focused on vascular receptors and their role in health and disease, mainly on the endothelium-derived factors endothelin and nitric oxide. Dr. Dashwood has published a number of research articles and reviews on the potential beneficial role of perivascular adipose tissue. These studies have been conducted in collaborations with colleagues in countries including Germany, Sweden, Switzerland, Spain, Brasil and the USA and have generated over 200 publications in peer reviewed journals, many reviews and book chapters. Dr. Dashwood is presently an honorary staff member in the Department of Surgery and Interventional Sciences at the Royal Free Hospital/ University College London Medical School.
Professor Greg Dusting is Honorary Professor at the Centre for Eye Research Australia, formerly the Director of Tissue Engineering at the O’Brien Institute, and Honorary Professorial Fellow in Surgery and Ophthalmology at The University of Melbourne. In early years, he was a research scientist at Wellcome Research and had a pioneering role in producing a heart drug now on the international market. In Australia, his team has invented another drug to prevent heart failure developing after heart attacks, and this is now completing Phase 2 clinical trial. He is Associate Editor of 5 international journals, and was awarded the Michael Rand Medal for Pharmacology as well as The Heart Foundation Research Medal (2015) for groundbreaking cardiovascular research.
Dr. Mukherjee, M.D is the Chairman of the Department of Internal Medicine and the Program Director for the Cardiovascular Medicine Fellowship program at the Texas Tech University Health Sciences Center at El Paso. Dr Mukherjee has been an invited lecturer at several major national and international meetings, has authored over 450 publications, edited eighteen textbooks on cardiovascular diseases and written more than 100 textbook chapters.
Pal Pacher is the Chief of Laboratory of Cardiovascular Physiology and Tissue Injury at National Institute on Alcohol Abuse and Alcoholism of National Institutes of Health USA. He co-authored over 300 peer-reviewed publications and listed among top 50-100 most cited researchers in the World in Pharmacology and Toxicology fields since 2010, and also among the top 1% cited in Clinical Medicine, Biology and Biochemistry fields. He has also been listed in Highly Cited 2014 to 2016 in Pharmacology & Toxicology (based on number of highly cited papers and total citations) and was included in list of: ”The World’s Most Influential Scientific Minds 2014”, 2015 and 2016 Thomson Reuters.
Prof. Sobrevia obtained a masters (M.Sc.) in Physiological Sciences from the Universidad de Concepción, Chile, and a doctorate (Ph.D.) in Biomedicine and Physiology from the King’s College London, University of London, United Kingdom. Professor Sobrevia is also an Honorary Professor in the UQ Centre for Clinical Research (UQCCR), Faculty of Medicine and Biomedical Sciences, University of Queensland, Australia, and Honorary Professor in the Faculty of Pharmacy, Universidad de Sevilla, Spain. He has published more than 150 scientific publications, has acted as member of the editorial board for the journal Placenta (2010-2014), and is the founder of the Cellular and Molecular Physiology Laboratory (CMPL) first in the Faculty of Biological Sciences of the Universidad de Concepción (1996) and then in the Faculty of Medicine of the Pontificia Universidad Católica de Chile (2003).
Niki Katsiki, MSc, PhD, MD, FRSPH is a specialist in Internal Medicine. Her PhD was based on obesity-related peptides in diabetic patients. She is a Clinical Research Fellow in Hippokration University Hospital, Thessaloniki, Greece.
Dr Katsiki has participated in obesity, lipid, diabetes, peripheral artery disease and smoking cessation outpatient clinics. She has given lectures in several international conferences and participated in clinical trials. She was an Honorary Clinical Research Fellow at the Department of Clinical Biochemistry, RFH, University College London Medical School, UK. She is also a SCOPE member of the International Association for the Study of Obesity. Dr Katsiki has 192 publications papers listed in PubMed and more than 1,200 citations on the ISI, Core Collection.
Perez-Martinez, Pablo gained his medical degree from University of Cordoba in 1997 and subsequently obtained an MS in Nutrition and Metabolism, Ph.D. in Nutrition and Post-doc in Nutrigenomics from Human Nutrition Research Center on Aging from the Tufts University, Boston, MA. Currently, he is the Professor at the School of Medicine, University of Cordoba and Medical Staff in the Department of Internal Medicine at the Reina Sofia University Hospital, Spain. During his scientific career, he has been involved in several projects focused on the genetics factors predisposing to cardiovascular disease and their interaction with the environment and behavioral factors with special emphasis on diet and particularly on the gene-diet interaction determining metabolic syndrome, obesity, cardiovascular diseases and aging. Moreover, he has conducted several studies on the identification of dietary patterns, recognition of food and nutrients, which modulate cardiovascular risk. The part of information in scientific advice to the Ministry of the Environment, Rural and Marine (Spain), in the preparation of material necessary to request the EFSA health claims and health of olive oil was based on research conducted in the field of nutrition and olive oil was also given by Dr. Perez-Martinez. He is the member of the Spanish Society of Internal Medicine, Directive Board of the Spanish Society of Atherosclerosis (coordinator work group Lifestyle and Nutrition; former Treasury) and the Spanish Hypercholesterolemia Family Foundation.
Prof. Demosthenes Panagiotakos is a Professor of Biostatistics, Research Methods and Epidemiology. He is the vice Rector of Financial Affairs, Research and Development of the Harokopio University and Dean of the School of Health Science & Education at Harokopio University (2013-2016). Dr. Panagiotakos is also a visiting Professor at School of Arts and Sciences, Rutgers, the State University of New Jersey, visiting Professor of Medicine, at the Agricultural University of Athens. He is the Principal Investigator of 7 large–scale epidemiological studies. He has published 3 books, over 600 scientific papers in peer-reviewed international journals, as well as 50 papers in national journals and Conference proceedings and has more than 13.500 citations of his work (h-index of 55). He has received National and International Awards, Scholarships and many Awards from various Scientific Societies.
Dr. Khalid Al-Rasadi obtained his Medical Degree in 1998, and his postgraduate training in Medical Biochemistry at McGill University, Canada during 2002-2006. He spent another two years in Canada, working as a scientist at the Royal Victoria Hospital, McGill University, under the supervision of Prof. Jacques Genest. There he performed a number of studies on the molecular genetics of familial hypercholesterolemia and hypoalphalipoproteinemia. In that period Dr. Al-Rasadi also received training at the lipid clinic of the Royal Victoria Hospital, McGill University. He was also awarded a certificate in Clinical Lipidology by the National Lipid Association in the United State in 2008. Dr. Al-Rasadi is currently working as an associate professor in the department of biochemistry at the College of Medicine & Health Sciences at Sultan Qaboos University, Oman (SQU). He is the director of the medical research Center at SQU in Oman. He is one of the founder members of the Oman Society of Lipid and Atherosclerosis (OSLA) and its current President. Dr. Al-Rasadi has led several studies nationally and regionally such as the Gulf Familial hypercholesterolemia Study, and the Oman FH Cascade Screening Study. Dr. Al-Rasadi is a member of national and international medical associations and a member of Oman Medical Journal. He has more than 100 publications.
Dr. Smaragdi Antonopoulou is Professor of Biochemistry, Director of the Laboratory “Biology, Biochemistry and Physiology” at the Department of Nutrition and Dietetics and Dean of the Scholl of Health Science and Education, at the Harokopio University. She has nearly 30 years of experience in the research of Lipid metabolism and Platelet-Activating Factor (PAF) as well as in isolation, purification and identification of bioactive lipids from natural sources, aimed to treat cardiovascular diseases. During her career, she has supervised a significant number of doctoral theses and authored more than 100 manuscripts and 5 patents.
Paola graduated as a Midwife in 1996 from the Universidad de Concepción, Chile. She specialized in Perinatology in 1998 and trained in NICU. In 2003, she obtained her MSc and later in 2007 her PhD both in Biological Sciences/Physiology. Presently, she is an Associate Professor at the Division of Obstetrics and Gynecology, and the Division of Pediatrics, Department of Neonatology, in the School of Medicine at PUC since 2014. She is the leader of the Programming and Perinatal Epigenetics Lab. She has published over 50 full papers, has led 3 associative national grants (Fondef, Anillo, £450.000 each), 4 Fondecyt national grants (£200.000 each) and co-investigator in 9 Fondecyt proposals. She is a Reviewing Editor for Current Vascular Pharmacology and Editor in Ars Medica (PUC, Chile).
Prof. Undurti N Das is a practicing physician and also a scientist with an MD in Internal Medicine from India. E is President and CEO of a privately held biotech company: UND Life Sciences, Federal Way, WA, USA and also Professor and Director of BioScience Research Centre (BSRC), GVP College of Engineering Campus, Visakhapatnam, India and Professor of Medicine at GVP hospital. Dr. Das published more than 500 research papers and was awarded USA patents. Dr. Das is also Editor-in-Chief of journal Lipids in Health and Disease published by BioMed Central of UK/USA; Review Editor of journal Nutrition of Elsevier and Academic editor of journal: Medicine.
Dr. De Carlo obtained a degree in Cardiology and a doctorate in Cardiopulmonary pathophysiology from the University of Pisa, Italy. Dr. De Carlo is vice-director of the Cardiac Catheterization Laboratory and Professor at the School of Specialization in Cardiology in the University of Pisa. He has authored 140 scientific papers, particularly focussed on coronary, carotid and peripheral artery disease, and valvular heart disease. Dr. De Carlo is the Chairperson of the Working Group on Aorta and Peripheral Vascular Diseases of the European Society of Cardiology and is a coauthor of the Guidelines on Peripheral Artery Diseases of the same Society.
Giuseppe Dattilo is a MD specialized in Cardiology, with an advanced certification in "Angiological Diagnostic and Phlebology" and a PhD in "Methods and Techniques of Cardiovascular Imaging". He was actively involved in the Department of Intensive and Interventional Cardiac Therapy, University of Messina, Italy. He is Professor in several courses of cardiovascular ultrasound: Transthoracic and Transoesophageal Echocardiography, Stress Echocardiography, Transcranial Doppler. From 2009 to 2012, he was actively involved in the field of Electrophysiology and Cardiac Pacing at the Hospital of Urbino, Italy. Since 2012, he is an Assistant Professor of Cardiovascular Diseases for the degree courses of Medicine, Nursing Sciences, Food Sciences and in the Specialization School of Cardiology at the University of Messina, Italy. He is author of over 70 scientific publications with a total impact factor of 235 (H Index = 17). His main scientific activity is currently the application of modern echocardiographic techniques for early unmasking of coronary artery disease and the involvement of psoriasis as a cardiovascular risk factor.
Prof. Elisaf was born in 1954 in Ioannina, Greece. He graduated from the School of Medicine, University of Athens in 1979.He worked at the Institute of Lipids and Atherosclerosis Research, Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, University of Tel-Aviv, Israel (1993-1994). Currently, he is Professor of Internal Medicine at the University of Ioannina, Medical School (Greece) and Director of the 2nd Department of Internal Medicine and Division of Nephrology (University Hospital of Ioannina). He is also Head of the Lipids, Atherosclerosis, Obesity and Diabetes Department. He is an active member 27 medical societies such as European Society of Hypertension.
Albert Ferro studied Medicine at King’s College London (1978-1984), obtaining a 1st Class Honours intercalated BSc degree in Biochemistry in 1981. He did his PhD in Clinical Pharmacology at Cambridge University. He has been a Consultant Physician at Guy's and St Thomas' Hospitals in London since 1996, and was appointed Professor of Cardiovascular Clinical Pharmacology at King’s College London in 2009. He is ex-Vice-President (2005-2007) of the British Pharmacological Society. He chairs the MRCP Part 1 Board, and also the Royal College of Physicians Joint Specialty Committee on Clinical Pharmacology & Therapeutics. He is a member of a number of professional societies, and also serving as editorial boards member in several medical and cardiovascular journals.
Dr. Theodosios D. Filippatos is currently an Assistant Professor in the Department of Internal Medicine, School of Medicine, University of Crete, Greece. His scientific interests are in the field of diabetes, obesity, lipid metabolism and atherosclerosis. Dr. Filippatos has around 115 publications in peer-reviewed international journals and also he is presently Editorial Board Member of 7 scientific medical journals.
Prof. Ioanna Gouni-Berthold is a professor of Medicine at the University of Cologne since 2007. She studied medicine at the Aristotelian University of Thessaloniki, Greece where she graduated as a valedictorian. She trained at various Universities in the USA. Diabetes and Metabolism. Since 2005, she is senior registrar at the Polyclinic for Endocrinology, Diabetes and Preventive Medicine at the University of Cologne. Her research focus involves translational research in the field of lipid metabolism and lipid-modulating drugs. She has authored more than 100 papers and published her research in leading Journals. She is a member of various international boards and a reviewer for a number of high-ranking Journals.
Dr Ignatios Ikonomidis is Associate Professor in Cardiology in the 2nd Cardiology Department, Attikon Hospital, Medical School of the National and Kapodistrian University of Athens, Greece. He is the Head of the Echocardiography and director of the Laboratory of Preventive Cardiology of the 2nd Cardiology Department. He works in the field of non- invasive cardiovascular imaging. He has a national and worldwide reputation and is regarded as one of the leading experts in the field echocardiography and inflammation in CV diseases. As a result, he is a member of the accreditation committee for cardiac ultrasound for European Association of Cardiovascular Imaging Certification and Greek Health Authorities and a fellow of the European Society of Cardiology. He was a nucleus member of the ESC WG of Aorta and Peripheral Vascular Diseases (2018). He has published over 200 original papers with over 5000 citations and contributed in several medical textbooks. He has a particular interest in vascular imaging and investigated the effects of vascular function on cardiac function especially after therapeutic interventions.
Vladimir jakovljevic is the full professor of Physiology at Faculty of Medical Sciences, University of Kragujevac. He received his Post graduate training in Clinical Physiology at Belgrade University School of Medicine. He is the President at Serbian Physiological Society and has finished 20 PhD thesis as a mentor.
Dr. Jorge Emilio Jalil obtained his M.D. degree in 1980 from the Medical School of University of Chile, Santiago, Chile. Dr. Jalil is currently Full Professor of Medicine at the Pontifical Catholic University of Chile, Santiago, Chile. Additionally, he is Director of the Non Invasive Cardiac Lab at the Clinical Hospital of Pontifical Catholic University of Chile. His skills and expertise mainly lie in the subject areas/fields of Cardiology, Internal Medicine (General Medicine), Cardiothoracic Surgery, Diabetology, Nephrology, Hepatology, Bariatric Surgery, Gastroenterology, Oncology, Traumatology, etc. Dr. Jalil, as an author/co-author, has published more than 95 articles in various journals, having a considerable number of total citations, i.e. over 2,855.
Dr. Wei Kong is a professor of Physiology at Peking University Health Science Center, China. She obtained her MD and Ph.D degree at Tongji Medical University, Wuhan, China in 2000. She pursued her postdoctoral training at the University of Washington, Seattle and New York University, NYC during 2001 to 2005. She was appointed professor in Peking University in 2010 and awarded China National Funds for Distinguished Young Scientists in 2012. She has also served as President for Chinese Society of Matrix Biology and editorial board member of “Curr Vasc Pharmacol”. Her research interest has focused on extracellular matrix remodeling during the pathogenesis of cardiovascular disease. In the past 5 years, she has published 50 peer-reviewed papers in highly impacted scientific journals including Circulation，Blood, etc.
Rigas G. Kalaitzidis is a Nephrologist, Director of NHS (National Health System) at the Division of Nephrology at the University Hospital of Ioannina in Greece. He received his medical degree from the University of Ioannina in Greece. He completed his residency in Internal Medicine in the General Hospital in Arta and then completed a fellowship in Nephrology in the Department of Nephrology at the University Hospital of Ioannina in Greece. He also completed a Training Course as a research fellow in Nephrology and Hypertension in Blood Pressure Unit at St. George’s Hospital in London. He was a Senior Registrar in Nephrology at the Renal Unit in the General Hospital of Filiates in Thesprotia in Greece. Additionally, he completed a Training Course as a research fellow in Nephrology and Hypertension in the Hypertension Unit, Section of Endocrinology at the University of Chicago School of Medicine in Illinois.
Dr. Ravinder has done his MS (Pharm.) and Ph.D. in Pharmacology and Toxicology from NIPER-SAS nagar, India. He received his postdoctoral training at Yale School of Medicine, USA and Icahn School of medicine at Mount Sinai, NY. Dr. Ravinder has made an outstanding contribution in the field of pharmacological research and has elucidated the involvement of various pathogenic pathways like oxidative stress, PARP overactivation, inflammation and apoptosis in cerebral ischemic-reperfusion injury and diabetic neuropathy. Gene regulation is another of his interest and he has developed various tools/methods to study the mechanisms of epigenetic memory. His work is published in journals of high repute and is highly cited. He is reviewer and editorial boardmember of several international journals.
Yue Liu MD, PhD is the associate professor of cardiology and gerontology. Dr. Liu achieved PhD in Integrative Medicine from China Academy of Chinese Medical Sciences. His research mainly focuses on Chinese Medicine clinical assessment as well as in purification and identification of bioactive from natural sources or Chinese medicine, such as ginkgo biloba, tetramethylpyrazine and ginsenoside, aimed to treat atherosclerosis, diabetes and cancer. He was funded by over 7 projects and has published over 70 articles in peer-reviewed journals. He is also a practicing certificate for registered Chinese medicine practitioner; his clinical specialty is in Chinese medicine treatment of cardio-cerebrovascular diseases and anxiety or depression. He is on the editorial board and is a reviewer for several cardiology and gerontology journals.
Aurelio Leone is a Physician and Researcher. He did his first job at the Pathological ,Anatomy Institute of the University of Roma. In 1969, he worked as a Medical Researcher at the CNR Institute of Clinical Physiology and then as a clinical Cardiologist in La Spezia, from 1973 to 1985. He was the Director of the Medical Division of Pontremoli City Hospital, from 1985 to 1999, he was chief of the Department of Internal Medicine of City Hospital in Massa, from 1999 to 2002. At present, he is an independent researcher (Castelnuovo Magra, Italy), fellow of the Royal Society for Promotion of Health, London, UK (FRSPH), and Fellow of the American Society of Hypertension (FASH), as well as member of the World Heart Federation (WHF).
Andrzej Loesch is a Polish and British cell biologist. He didMSc, DSc from Jagiellonian University, Krakow; PhD in Medical Sciences from the Polish Academy of Sciences Mossakowski Medical Research Centre, Warsaw where he is also serving as Professor. In 1989, he joined the University College London (UCL), Department of Anatomy and Developmental Biology and Centre for Neuroscience, and also the Autonomic Neuroscience Institute/Centre. Presently, he is an Honorary Academic at the UCL Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases. He is a Fellow of the Royal Society of Biology and a member of several editorial boards of biomedical journals. Dr. Loesch authored many publications in the field of electron-immunocytochemistry of vasoactive agents and the fine structure of the vascular system, and its relationship with the autonomic nervous system. Other works include collaborative research on graft materials for coronary artery bypass surgery.
Professor Lovic Dragan MD, PhD is a specialist in internal medicine and cardiology, chief of the Hypertension Center, Cardiology department at Clinic for internal diseases Intermedica, in Nis, Serbia. He is a Professor of internal medicine at Singidunum University Medical School, Nis, Serbia. His main areas of interest for teaching and research are hypertension, coronary heart disease, heart failure, arrhythmias, and cardiovascular prevention. He has published more than 90 papers (total citation 5640) in international and national journals. He is elected Council Member of the European Society of Hypertension since 2016. Professor Lovic is a Fellow of the American College of Physicians (FACP), Fellow of European Society of Cardiology (FESC), Fellow of European federation of Internal Medicine (FEFIM), Specialist of Hypertension of European Society of Hypertension, Past President of the Serbian Society of Hypertension.
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Dr. Nikolaos Papanas is Associate Professor in Internal Medicine at Democritus University of Thrace, Greece. He has specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King’s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, Düsseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in Düsseldorf. He has published more than 220 papers in peer-reviewed journals and serves in the editorial board of 25 international journals. He has also participated in numerous presentations in Greek and European medical congresses and repeatedly served as invited reviewer in medical journals. He has served in the Executive Committee of the Hellenic Society for Angiology. He has served as Secretary General and is currently the President of the Hellenic Diabetes Association.
Prof. Olga Pechanova is a director of Institute of Normal and Pathological Physiology, Slovak Academy of Sciences (INPP SAS) and president-elect of International Society of Pathophysiology. She has 30 years of experience in the cardiovascular research and development of medications aimed to treat hypertension and cardiovascular consequences. During her career at SAS, Prof. Pechanova holds a Ph.D. Prof. Pechanova has authored more than 150 manuscripts, 1 patent, and co-author of several monographs, H-index 31. She also teaches at Faculty of Natural Sciences, Comenius University, Bratislava "Biochemical Physiology", a class focused on science. She also served as visiting-professor at Kragujevac University and Osaka University.
Evangelos C Rizos, MD, PhD, is a Consultant in Internal Medicine, Diabetologist, at the University Hospital of Ioannina, Greece. He is a former visiting Assistant Professor of the Internal Medicine at the University of Cyprus Medical School, Honorary Clinical Research Fellow of the Molecular Pathology - Clinical Biochemistry Department of the Royal Free Hospital in London, and a National Expert on Secondment for the Scientific Advice and Orphan Drugs Sector in the EMA, London. He also serves as the Principal or Co-investigator for 30 randomized clinical trials and is an author of 65 papers with 2532 citations, h-index 23. He is an expert for ECDC and a member of D&CVD EASD study group.
Prof. Rizzo is Associate Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy as well as Associate Professor of Internal Medicine at the School of Medicine, University of South Carolina, USA. Prof. Rizzo sits on the editorial board of 9 international journals with Impact Factor. He has been the recipient of national and international fellowships and awards, and acted as reviewer for 100+ scientific international journals. The research work of Dr. Rizzo combines translational research (focus on the effects and mechanisms of action of lipid-¬‐lowering and anti-¬‐diabetic agents) and basic research (focus on novel cardiovascular risk factors), with 200+ scientific publications with Impact Factor.
Vincenzo Russo graduated in Medicine and Surgery from the Second University of Naples (SUN) in 2005. He achieved the Specialization Degree in Cardiology in 2010. He received a Master’s Degree in Clinical Training and Management in Cardiology at the University of Padua in 2011. Later, he earned a Ph.D. degree in Pathophysiology of the Cardio-Respiratory System from the Second University of Naples in 2013. He actually serves as a Consultant Cardiologist and Electrophysiologist at Monaldi Hospital in Naples and as an Assistant Professor in Cardiovascular Diseases at the School of Medicine - University of Campania “Luigi Vanvitelli.”
Prof. Szabo is an internationally recognized expert in the fields of oxidative and nitrosative stress, gaseous transmitters, cell death, cell dysfunction, cardiovascular, and inflammatory mechanisms. Over the last decade, he has developed a significant track record in the biology of hydrogen sulfide, where he has identified multiple regulatory roles of this mediator in angiogenesis, reperfusion injury, and cancer. He was recently listed as one of the top 400 most influential biomedical scientists in the word. He has received numerous awards, including the Novartis Award of the British Pharmacological Society, the Texas Star Award and the Pharmacia-ASPET Award for Experimental Therapeutics. He serves on the Editorial Board of numerous leading journals. He is an Elected Fellow of the British Pharmacological Society and an Elected Member of the American Society for Clinical Investigation.
Dr. Sabato Sorrentino, MD, PhD, is a post-doctoral fellow in Cardiology at Magna Graecia University, Italy, and previously research fellow at the Department of Interventional Cardiovascular Research and Clinical Trials, Mount Sinai in New York (2016-2018). Dr. Sorrentino is Fellow of the Italian Society of Cardiology and a member of several international scientific associations. He is involved in experimental and theoretical studies on biomarkers of new generation in the treatment and prevention of cardiovascular diseases, coronary flow, bioresorbable vascular scaffolds and drug eluting stents. Furthermore Dr. Sorrentino is involved in “in vitro” and “in vivo” protocols concerning the study of restenosis, post-infarct remodeling and limb ischemia. Dr. Sorrentino is, also, a reviewer and editorial board member of high-quality peer-reviewed journals.
Stefano Taddei attended the State University of Pisa, where he graduated in Medicine and Surgery in 1982 and specialized in Clinical Pharmacology in 1986. Prof. Taddei is a Professor of Internal Medicine. He works currently as the Director of the Hypertension Unit of the Department of Clinical and Experimental Medicine. Prof. Taddei is a Fellow of the European Society of Cardiology, He has been a councilor of the Italian Society of Hypertension (2007-2009). He is a editorial board member of Hypertension, Blood Pressure, Journal of Cardiovascular Pharmacology, Current Vascular Pharmacology, Current Hypertension Reviews, etc. He is an International Associate Editor of the European Heart Journal. His main research area is local neuro-humoral control of peripheral vessels in primary and secondary forms of hypertension, with particular emphasis on the sympathetic nervous system, the renin-angiotensin system and the endothelium. Prof. Taddei has participated in numerous clinical studies and is the authors of more than 300 original papers, reviews and editorials in international scientific journals.
Turgut Tatlisumak obtained his MD degree in 1986 and trained in neurology and stroke at the Helsinki University Central Hospital. He was a research fellow at the University of Massachusetts in 1995-1996. He holds a PhD degree and a degree in pedagogics. He is a specialist in neurology and health care administration. Dr Tatlisumak is currently professor of neurology and stroke medicine at the University of Gothenburg and chief physician at the Sahlgrenska University Hospital, Gothenburg, Sweden. He is a fellow of AHA and ESO. Dr Tatlisumak's research is concentrated on stroke. He has published approx. 300 scientific papers.
Vasilis Tsimihodimos, was born on September 25, 1971 in Greece. He is an Assistant Professor in Internal Medicine, Medical School, University of Ioannina, Greece. He got his Medical Diploma from Medical School University of Ioannina. He served as a Military Doctor and was in charge of a battalion of the Greek Army from 1998- 2000. He received his Doctoral Diploma (Ph.D.) in Internal Medicine, in 2014. In 2007, Vasilis Tsimihodimos, was appointed as Registrar in Internal Medicine. He later specialized in Diabetology from Athens General Hospital “Evangelismos”. He is also a fellow member of Hellenic Atherosclerosis Society, European Atherosclerosis Society and Hellenic Medical Association for Obesity.
Dr. Tsin received his Ph.D. degree from the University of Alberta in Edmonton, Alberta, Canada and his postdoctoral training at the Baylor College of Medicine in Houston, Texas. Currently, Dr. Tsin is the Chair of the Department of Biomedical Sciences and Associate Dean of Research in the School of Medicine at the University of Texas Rio Grande Valley in Edinburg, Texas. Dr. Tsin conducts research to investigate the mechanism of visual pigment regeneration in the cone visual system and the development of ocular diseases due to diabetes and other metabolic/genetic complications.
Dr. Tziakas was born in Alexandroupolis on March 27, 1967. He gained his PhD in Cardiology in 2000 from the University Cardiology Clinic, Democritus University of Thrace. He worked as a Senior Registrar in Cardiology for two years. He was a Lecturer in Cardiology at Democritus University of Thrace, from 2001 to 2005. He has also worked as Assistant Professor till 2012. He then Head the Cardiology Department of Democritus University of Thrace, University Hospital of Alexandroupolis. Dr. Tziakas is Research Fellow in Coronary Artery Disease Research Unit, Cardiological Sciences Department at St George’s University of London. His fields of interest are Acute Cardiac Care and acute decompensation of chronic heart failure.
Dr Adie Viljoen is Consultant Chemical Pathologist Metabolic Medicine at the Lister Hospital in Stevenage and Honorary Consultant at Cambridge Universities NHS Trust. He conducts multiple phase 2, 3 and 4 clinical trials in Diabetes, Obesity and Lipids. He was the UK Chief Investigator on the EXAMINE study of alogliptin and the European Principal Investigator for the ongoing SUSTAIN-7 study in type 2 diabetes.
He is a Senior Lecturer in Medicine at the Hertfordshire Postgraduate Medical School and is the author of more than 75 papers in peer reviewed medical journals as well as the author of more than 10 chapters in medical textbooks including the Oxford Textbook in Diabetes. He recently co-authored a book on Cardiovascular Risk. Dr Viljoen was a topic expert on NICE Quality Standards and Technology Appraisals.
Dr. Marcelo Vatta obtained both a MS in Biochemistry and PhD degree (Physiology) from the School of Pharmacy and Biochemistry at the University of Buenos Aires (UBA), Argentina. He completed postdoctoral studies at the University of Ottawa Heart Institute, Canada, under the supervision of Dr. Adolfo J. De Bold. Currently, Dr. Vatta is an Associate Professor of Physiology at the School of Pharmacy and Biochemistry, UBA, and Principal Researcher of the National Council for Scientific and Technical Research (CONICET) at the Institute of Immunology, Genetics and Metabolism where he is the Head of the Cardiovascular Physiology and Pathophysiology Laboratory.
Prof. Luca Zanoli is an Assistant Professor of Nephrology at the University of Catania, Italy. He did his MD, PhD in Hypertension, FASN. He did a Long-term Fellowship of the ERA-EDTA (2010-12), he has also been the Principal Investigator of the project &Arterial structure and function in patients with inflammatory bowel disease& of the Italian Ministry of Health. Besides, he is also member of a number of societies such as European Society of Hypertension (ESH), the Association for Research into Arterial Structure and Physiology (ARTERY), etc. As author he has published 118 articles in SCOPUS and Web of Science. He has been the First author of 41 articles (31 articles on arterial structure and function).
Dr. Liakoppolus received his MD degree from the Aristotle University of Thessaloniki, Greece and PhD degree from the Democritus University of Thrace, Greece. He is currently an Associate Professor of Nephrology at the Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, Greece. Currently, he serves as a member (representing ISN) of the World Kidney Day Steering Committee. Additionally, he is actively involved in many Committees of the Medical School of the University (PhD Committee, MSc Committee, Bioethics Committee, Educational Committee etc.) and in the Administration Committee (RESTART) of the Aristotle University of Thessaloniki and is also the Vice-Chairman of the Research Ethics Committee of the University of Peloponnese, Greece.